Download the PDF poster:
Watch the presentation on-demand:
Presented at Digital Pathology & AI Congress USA 2025 | In support of the INCISE Project
As part of the INCISE project, an ambitious collaboration between the University of Glasgow, NHS Greater Glasgow and Clyde, and a network of industry partners, OracleBio led the Digital Pathology work package, helping to advance bowel cancer surveillance through scalable image analysis.
Our role focused on developing and deploying an automated pipeline to quantify Ki67 biomarker expression across a large cohort of colorectal polyp samples. This data forms part of a wider effort to create a multi-omics risk model that can help stratify patients and personalise future screening pathways.
What you’ll learn:
- A four-stage AI-driven image analysis workflow – Built in Visiopharm and validated by expert pathologists, our pipeline included tissue QC, adenoma classification, gland segmentation, and single-cell phenotyping.
- Execution at scale – The final pipeline was used to process over 2,200 Ki67-stained whole slide images, executed in parallel across 75 GPU-enabled cloud nodes.
- Fast, reliable performance – All 2,211 samples were analysed in just 45 hours—demonstrating the pipeline’s robustness, scalability, and future potential to support high-throughput diagnostic workflows.
Click the thumbnail above to download the full poster and see how OracleBio’s image analysis expertise is helping power the next generation of bowel cancer surveillance.
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more
You might also like these Posters:
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach
OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022. The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio. The work involved multiplex...
Utilizing Quantitative Digital Pathology techniques for analysis of Hepatitis B liver samples stained with a 12-plex multiplex-IF assay
OracleBio data is presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York. The poster, produced in collaboration with Gilead, involved a comprehensive evaluation of Hepatitis B liver samples stained using a 12-plex assay, with this poster...
A Quantitative Digital Pathology Workflow to Manage Technical Challenges within Multiplex IF R&D Studies
This poster, created in collaboration with Bristol Myers Squibb, details OracleBio's robust image analysis workflow in Indica Labs HALO, and how it helped overcome common technical issues encountered in a large multiplex IF (mIF) non-small cell lung cancer (NSCLC)...
